Several polymorphisms in the human iNOS gene have been described that are associated with a variety of diseases, including malaria [29-31] and hypertension [32]; it would be interesting to know if these or other polymorphisms affected responsiveness to DEC therapy. Here, NOS2 is linked to malaria.